KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Gains from Sales and Divestitures (2016 - 2021)

Resmed's Gains from Sales and Divestitures history spans 9 years, with the latest figure at $704000.0 for Q2 2021.

  • For Q2 2021, Gains from Sales and Divestitures fell 24.22% year-over-year to $704000.0; the TTM value through Jun 2021 reached $704000.0, down 24.22%, while the annual FY2021 figure was $704000.0, 24.22% down from the prior year.
  • Gains from Sales and Divestitures reached $704000.0 in Q2 2021 per RMD's latest filing, down from $929000.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $929000.0 in Q2 2020 to a low of $2911.0 in Q3 2018.
  • Average Gains from Sales and Divestitures over 5 years is $596515.5, with a median of $652065.0 recorded in 2018.
  • Peak YoY movement for Gains from Sales and Divestitures: crashed 68.56% in 2017, then skyrocketed 130.95% in 2019.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $624617.0 in 2017, then surged by 41.95% to $886655.0 in 2018, then fell by 2.86% to $861256.0 in 2019, then increased by 7.87% to $929000.0 in 2020, then fell by 24.22% to $704000.0 in 2021.
  • Per Business Quant, the three most recent readings for RMD's Gains from Sales and Divestitures are $704000.0 (Q2 2021), $929000.0 (Q2 2020), and $915450.0 (Q1 2020).